News

Data about the Activity of Moldovan Commercial Banks on July 31, 2025Dr. Sándor Csány: Being the 4th largest, OTP in Moldova will grow both organically as well as through possible mergers and acquisitions It seems to be a place, but it is notScott HOCKLANDER: For me, the persistence of Moldovan citizens is not only a learned lesson, but also a great exampleSorin MASLO: "The year 2022 was a turning point for the "Cricova" Wine Combine, the turnover increased by almost 25%"Deposit rates are at their peak. Market conjuncture or Why banks need individuals’ depositsValeriu LAZĂR: "If the state does not support business today, tomorrow it will have no one to collect taxes from.Chisinau Airport as a reflection of statehoodMonetary measures against non-monetary inflationBanks as the fulcrum of the economy: they have increased profits and are preparing for the challenges of the 2H 2022The Ministry of Finance and investors in the State Securities market at the peak of placement volumesThe banking market: turmoil and increased demand. No panicIs Moldova ready for the economic consequences of the war in the neighboring country?Are we heading for hyperinflation? It all depends on the correct diagnosis and the prescribed treatmentWhat is happening in the Government Securities Market and what does the National Bank have to do with it?The wine industry is on the verge of a revolution: Is the industry-specific law bankrupting enterprises? The trap for the oil products marketLászló DIÓSI: Foreign investments come to Moldova due to banking system stabilityWhen there is no program with the IMF, we issue are government securities ...Nikolay BORISSOV: “Acquisition of Moldindconbank is the best procurement in the Moldovan market, albeit the most risky one”Oil Ping Pong GamesBanking 2020 - pandemic, profitableWeird 2020: humility, depression, rebellion, accepting a new realityThe Hunger Games of the foreign exchange marketHow to tame liquidity?Veaceslav IONITA: The government killed the business, but flirted with the populationPeople and Business: Natural and Unnatural SelectionAlexandru BURDEINII: Being ethical becomes vital in business nowadaysMoldova’s Key Macroeconomic IndicatorsPrices at filling stations

COVID vaccine scientists win Nobel Prize in medicine

COVID vaccine scientists win Nobel Prize in medicine

The accolade, among the most prestigious in the scientific world, went to Katalin Kariko, from Hungary, and Drew Weissman, from the United States.
The Nobel Prize in medicine has been awarded to two scientists for their research which led to the development of effective mRNA vaccines against COVID-19.
The accolade, among the most prestigious in the scientific world, went to Katalin Kariko, from Hungary, and Drew Weissman, from the United States.
"Through their groundbreaking findings, which have fundamentally changed our understanding of how mRNA interacts with our immune system, the laureates contributed to the unprecedented rate of vaccine development during one of the greatest threats to human health in modern times," the panel that awarded the prize said.
Both COVID-19 vaccines Pfizer/BioNTech and Moderna use something called messenger RNA (mRNA) to send genetic instructions to the body's cells to recognise and destroy a particular part of the coronavirus called the spike protein.
When the body develops an immune response to this spike protein it is then able to fight off the coronavirus without having ever been exposed to the virus itself.
Ms Kariko is a professor at Sagan's University in Hungary and an adjunct professor at the University of Pennsylvania.
She was senior vice-president and head of RNA protein replacement at BioNTech until 2022 and has since acted as an adviser to the German firm.
Mr Weismann performed his prize-winning research with Ms Kariko at the University of Pennsylvania.
The two have said they met in 1998 while waiting for rationed photocopying machine time. The ensuing chat piqued immunologist Mr Weissman's interest in Ms Kariko's RNA work.
Advertisement
Thomas Perlmann, secretary of the Nobel Assembly, announced the prize and said both scientists were "overwhelmed" by the news when he contacted them.
"This year's Nobel Prize recognises their basic science discovery that fundamentally changed our understanding of how mRNA interacts with the immune system, and had a major impact on society during the recent pandemic," said Rickard Sandberg, a member of the Nobel Assembly at Karolinska Institute.
"Together they have saved millions of lives, prevented severe COVID-19, reduced the overall disease burden and enabled societies to open up again."
Dr Paul Hunter, a professor of medicine at the University of East Anglia, described the mRNA vaccines as a "game changer" in helping to shut down the coronavirus pandemic, crediting the jabs with saving millions of lives.
"If it hadn't been for the mRNA technology, COVID would have been much worse," he said.
"Vaccines generally were the turning point in slowing down COVID and the mRNA vaccines were just so much better than all the others.
"We would likely only now be coming out of the depths of COVID without the mRNA vaccines," he added.
Monday's announcement in Stockholm, Sweden, kicks off this year's awards with the remaining five to be unveiled in the coming days.
The prizes, first handed out in 1901, were created by Swedish dynamite inventor and wealthy businessman Alfred Nobel, and are awarded for achievements in physics, chemistry, literature and peace, and in later years also for economics.
They carry a cash award of 11 million Swedish kronor (£820,000). The money comes from a bequest left by the prize's creator, who died in 1896.

news.sky.com

News on the subject